A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma

NCT04154189 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

81

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteosarcoma

Interventions

DRUG: Lenvatinib
DRUG: Ifosfamide
DRUG: Etoposide
DRUG: Lenvatinib

Sponsor

Eisai Inc.

Collaborators

[object Object]